Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients.

ABSTRACT:

Background

Information regarding coronavirus disease 2019 (COVID-19) in haemodialysis (HD) patients is limited and early studies suggest a poor outcome. We aimed to identify clinical and biological markers associated with severe forms of COVID-19 in HD patients.

Methods

We conducted a prospective, observational and multicentric study. Sixty-two consecutive adult HD patients with confirmed COVID-19 from four dialysis facilities in Paris, France, from 19 March to 19 May 2020 were included.Blood tests were performed before diagnosis and at Days 7 and 14 after diagnosis. Severe forms of COVID-19 were defined as requiring oxygen therapy, admission in an intensive care unit or death. Cox regression models were used to compute adjusted hazard ratios (aHRs). Kaplan-Meier curves and

SUBMITTER: Mutinelli-Szymanski P 

PROVIDER: S-EPMC7717182 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature